Literature DB >> 6803325

Epidemic meningococcal disease: synthesis of a hypothetical immunoepidemiologic model.

J M Griffiss.   

Abstract

A hypothetical model of the epidermic behavior of Neisseria meningitidis, based upon the induction of susceptibility to disseminated disease by circulating IgA, is presented. The model is based on the assumption that epidemic susceptibility is acquired as a result of induction of serum IgA by cross-reacting enteric bacteria, the priming organism. Co-colonization with the appropriate strain of N. meningitidis then may result in disseminated disease. Colonization by either bacterium in the absence of the other results in reinforcement of the commensal relationship. Slow, silent, fecal-oral transmission of the priming organism determines the time/space characteristics of an epidemic; interruption of fecal-oral transmission aborts it. Aerosol transmission of the meningococcus determines the magnitude of an epidemic. Independent, age-related acquisition of both capsular polysaccharide and lipopolysaccharide antibodies provides immunity in the absence of aberrantly high levels of co-specific serum IgA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6803325     DOI: 10.1093/clinids/4.1.159

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  20 in total

1.  Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in the People's Republic of China.

Authors:  J F Wang; D A Caugant; X Li; X Hu; J T Poolman; B A Crowe; M Achtman
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

Review 2.  Global epidemiology of meningococcal disease.

Authors:  B Schwartz; P S Moore; C V Broome
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

3.  Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose.

Authors:  M M Estabrook; J M Griffiss; G A Jarvis
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

Review 4.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

5.  Risk of group A meningococcal disease: bacterial interference and cross-reactive bacteria among mucosal flora.

Authors:  G A Filice; P S Hayes; G W Counts; J M Griffiss; D W Fraser
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

6.  Meningococcal disease in Los Angeles County, 1981 through 1990.

Authors:  J C Thomas; N S Bendana; S H Waterman
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

7.  Serum IgA: modulation of complement activation and induction of susceptibility to bacterial dissemination.

Authors:  J M Griffiss
Journal:  Infection       Date:  1982       Impact factor: 3.553

Review 8.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

Review 9.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03

10.  Localization of distinct surface antigens on Chlamydia trachomatis HAR-13 by immune electron microscopy with monoclonal antibodies.

Authors:  R B Clark; I Nachamkin; P F Schatzki; H P Dalton
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.